Cargando...
Short-course combination treatment for experimental chronic Chagas disease
Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, affects millions of people in the Americas and across the world leading to considerable morbidity and mortality. Current treatment options, benznidazole (BNZ) and nifurtimox, offer limited efficacy and often lead to adverse side eff...
Gardado en:
Publicado en: | Sci Transl Med |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado: |
2023
|
Assuntos: | |
Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7615676/ https://ncbi.nlm.nih.gov/pubmed/38091410 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.adg8105 |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|